Clinical Trial

Oncometabolic Surgery

Study acronym: KLASS-09
Completed Phase 3
View on ClinicalTrials.gov →
Summary
Recently, the concept of "Onco-metabolic surgery" has emerged, and it is a theory that if anastomosis bypassing the duodenum and upper jejunum is performed after gastrectomy in gastric cancer patients with type 2 diabetes, diabetes can be expected to improve. The authors would like to compare and analyze the effect of long bowel Luwai gastrointestinal anastomosis in gastric cancer patients with type 2 diabetes in a multicenter prospective manner with that of type 2 diabetes gastric cancer patients who underwent a conventional Luwai gastrointestinal anastomosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-24.
Trial Details
NCT Number NCT07437573
Lead Sponsor Korea University Guro Hospital
Collaborators: Kyungpook National University Chilgok Hospital, Samsung Medical Center, Asan Medical Center, Seoul National University Bundang Hospital, Kyung Hee University Hospital at Gangdong, Kosin University Gospel Hospital, Dankook University, Korea University Ansan Hospital, Seoul National University Hospital, Gangnam Severance Hospital, Keimyung University Dongsan Medical Center, Wonju Severance Christian Hospital, Gyeongsang National University Hospital
Conditions Gastric Cancer
Enrollment 94 participants
Start Date 2020-07-07
Primary Completion 2024-05-07 (estimated)
Study Completion 2024-05-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-27